Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,576 | -25,214 | -17,744 | -12,302 | -6,580 |
| Depreciation Amortization | 1,066 | 1,656 | 260 | 156 | 51 |
| Accounts payable and accrued liabilities | -304 | 1,469 | 107 | -1,730 | -1,851 |
| Other Working Capital | 49 | 1,551 | 168 | -1,677 | -1,884 |
| Other Operating Activity | -1,722 | 4,524 | 3,134 | 2,738 | 2,459 |
| Operating Cash Flow | $-2,487 | $-16,014 | $-14,075 | $-12,815 | $-7,805 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -500 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | -10 | -11 | -5 | N/A |
| Net Acquisitions | N/A | -900 | -5,098 | -900 | -900 |
| Purchase Sale Intangibles | N/A | -4,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -4,000 | 0 | 0 | -1 |
| Investing Cash Flow | $-500 | $-4,910 | $-5,109 | $-905 | $-901 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 3,075 | N/A | 2,850 | N/A |
| Debt Issued | N/A | 4,605 | N/A | N/A | 2,850 |
| Debt Repayment | -100 | -105 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 2,883 | 2,833 | 2,820 | 2,820 |
| Other Financing Activity | 3,011 | 10,428 | 16,415 | 8,151 | 2,931 |
| Financing Cash Flow | $2,911 | $20,886 | $19,248 | $13,821 | $8,601 |
| Beginning Cash Position | 176 | 214 | 214 | 214 | 214 |
| End Cash Position | 100 | 176 | 278 | 315 | 109 |
| Net Cash Flow | $-76 | $-38 | $64 | $101 | $-105 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,487 | -16,014 | -14,075 | -12,815 | -7,805 |
| Capital Expenditure | N/A | -10 | -11 | -5 | N/A |
| Free Cash Flow | -2,487 | -16,024 | -14,086 | -12,820 | -7,805 |